Want to see EMMA full AI Analyst Report?
Emmaus Life Sciences (EMMA) Financial Statements
Emmaus Life Sciences Financial Overview
Emmaus Life Sciences's market cap is currently $2.47M. The company's EPS TTM is $-0.09; its P/E ratio is -0.37; Emmaus Life Sciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Jun 24 | Dec 22 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 12.45M | $ 16.65M | $ 29.60M | $ 18.39M | $ 20.61M |
| Gross Profit | $ 11.60M | $ 15.45M | $ 28.25M | $ 15.80M | $ 17.30M |
| Operating Income | $ 231.00K | $ -1.89M | $ 3.54M | $ -6.59M | $ -6.13M |
| EBITDA | $ -310.00K | $ -910.00K | $ 3.62M | $ -5.50M | $ -12.76M |
| Net Income | $ -7.49M | $ -6.45M | $ -3.73M | $ -10.63M | $ -15.95M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.13M | $ 1.39M | $ 2.55M | $ 2.02M | $ 2.28M |
| Total Assets | $ 21.44M | $ 23.60M | $ 35.18M | $ 48.23M | $ 56.73M |
| Total Debt | $ 32.56M | $ 32.96M | $ 32.65M | $ 30.82M | $ 29.91M |
| Net Debt | $ 30.43M | $ 31.57M | $ 30.10M | $ 28.80M | $ 27.64M |
| Total Liabilities | $ 85.04M | $ 80.08M | $ 82.94M | $ 82.32M | $ 78.18M |
| Stockholders' Equity | $ -63.61M | $ -56.48M | $ -47.76M | $ -34.09M | $ -21.45M |
| Cash Flow | |||||
| Free Cash Flow | $ -12.00K | $ -2.30M | $ -1.52M | $ -5.10M | $ -1.33M |
| Operating Cash Flow | $ -11.00K | $ -2.29M | $ -1.50M | $ -5.07M | $ -1.25M |
| Investing Cash Flow | $ 2.17M | $ 2.50M | $ -432.00K | $ -2.39M | $ -6.38M |
| Financing Cash Flow | $ -1.43M | $ -1.35M | $ 2.48M | $ 7.23M | $ 7.41M |
Currency in USD
